Compare GSK plc (GSK) vs Western Union Co (WU) Price & Performance

GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.

GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.

Western Union (WU) trades at $8.275, up 5.01% in the last session, with a bullish technical signal from moving averages. The stock shows strong profitability with a 10.88% net income margin and 47.66% ROE, though recent Q1 2026 earnings missed expectations. Valuation ratios appear attractive with a P/E of 5.91 and P/S of 0.64. Recent developments include a partnership with Total Wireless for fee-free money transfers and progress on the Intermex acquisition, enhancing digital reach.

Outlook is mixed: low valuations and dividend yield near 5.8% offer value, but declining revenue from $4.5B in 2022 to $4.0B projected for 2026 poses growth concerns. Risks include high debt levels and competitive pressures. Analysts are cautious with a consensus hold rating and $7.50 price target below the current price, indicating limited upside potential amid execution challenges.